Thomas Mcconnell

Thomas C. McConnell is a Managing Director investing in medical technology companies. Tom is a 22-year venture capital veteran who has demonstrated a solid track record of investment success and a personal commitment to the boards and organizations on which he has served. Tom was named to the Forbes Midas List in 2007 in recognition of liquidity realized between 2002 and 2006. Prior to joining Vanguard, Tom was a General Partner at New Enterprise Associates (NEA). He spent the first 14 years of his venture capital career investing in medical device and biopharmaceutical companies. Twenty of the healthcare companies in which he invested went public and nine were acquired while private. In 1998 he was recognized by VentureOne as one of the top two venture investors in the medical device sector based on the market value of companies where he held a board seat. During his last five years at NEA, he invested in infrastructure technologies such as communications equipment, optical components, networking semiconductors and software.During his career, McConnell also has played a leadership role in the venture capital industry. He served as Chairman of the National Venture Capital Association (NVCA) in 2001-02 and as President of the Western Association of Venture Capitalists (WAVC) in 1995-96. Before becoming a venture capitalist in 1985, McConnell was a product manager at Apple Computer and a consultant with the Boston Consulting Group. He received an A.B. in Engineering Science, Summa Cum Laude, from Dartmouth College and an MBA with honors from the Stanford University Graduate School of Business. Tom is a member of the Board of Directors of Asthmatx , Dfine and Hansen Medical .AsthmatxDfineHansen MedicalAdministrative assistant: Shari Palmer-Leith shari@vanguardventures.com 650-321-2900Administrative assistant:shari@vanguardventures.com

Clarendon Photonics